Background: It has been suggested that a surgeon's experience and training are the most important factors associated with graft selection, but no studies have qualified this association. Graft usage prevalence has not been described for large anterior cruciate ligament reconstruction (ACLR) populations in the United States.
Anterior cruciate ligament reconstruction (ACLR) graft selection is usually based on the surgeon's professional experience, understanding of the literature, and patient preference. 21 Factors considered by the surgeon during graft selection for a procedure may include reported graft failure rates, donor site morbidity, familiarity with graft, surgical time, patient-reported functional and quality of life outcomes, possible postoperative complications, and associated costs. [6] [7] [8] 21 However, the most appropriate type of graft for any given patient population continues to be a debated topic in the orthopaedic community, with several systematic literature reviews and meta-analyses published and no definitive conclusions reached. [3] [4] [5] [10] [11] [12] 19 While surgeons' experience and training may be the most common factors associated with graft selection, no studies have attempted to quantify this association. With the lack of large clinical studies, observational cohorts, and administrative information in this population, not even prevalence of graft usage has been described for a large community-based sample in the United States or countries without ligament registries. Furthermore, few studies have investigated other factors that could be associated with determination of a graft source. 6, 7 Given the current dilemma surrounding the optimal graft selection for any given patient population, we decided to evaluate preoperative variables available to surgeons that may be associated with graft choice. Understanding the influence of patient, surgeon, and site factors in the variability of graft selection might help to explain the most important determinants in graft selection.
The purpose of this study was to describe the prevalence of the type of graft used during primary ACLR surgery in a large community-based practice setting. In addition, we have evaluated the associations of patients' gender, age, race, body mass index (BMI), surgeon training, and yearly average volume of surgeon and hospital in the choice of hamstring autograft, bone-patellar tendon-bone (BPTB) autograft, and allograft for primary ACLR surgery. Our study did not attempt to imply causality or suggest what graft choices are better for patients.
MATERIALS AND METHODS

Study Design and Data Collection
A cross-sectional study of patients undergoing primary ACLR between February 1, 2005 and June 30, 2010 was conducted. The Kaiser Permanente (KP) ACLR Registry was used to identify all primary ACLRs performed during the study period. The registry has 42 contributing medical centers and 214 contributing surgeons, which are part of a large integrated health care delivery system. The KP ACLR Registry collects comprehensive intraoperative and postoperative information on all ACLRs performed at the participating sites. 18 The participating sites are located in California, Colorado, Hawaii, the Pacific Northwest, and Mid-Atlantic states. Intraoperative information is collected by the surgeon at the point of care using a paper-based 3page form. Upon completion, the form is sent to the KP ACLR Registry data repository center where the information is entered into an SQL database and data quality control routines are applied. The health care delivery system does not have any policies restricting or incentivizing the use of any type of graft used in these procedures, and the graft chosen is solely based on the surgeon's and/or patient's discretion. Institutional Internal Review Board approval for the study was obtained before study commencement.
Study Population
All patients in the registry were eligible for inclusion in the study. Patients were included in the study if the procedure was the primary ACLR in the operated knee. Patients were excluded if they had any concomitant ligament injury (medial collateral, lateral collateral, or posterior cruciate) at the time of surgery.
Exposure Assessment
Patient characteristics (BMI, age, gender, race) as well as grafts used during the procedure were obtained from the KP ACLR Registry. Surgeon training (current fellow or completed sports medicine fellowship) was ascertained using an e-mail and telephone-based survey. Annual ACLR volumes for surgeon and site were calculated based on the average volume of procedures performed per 12month period. The independent variables BMI and age were treated as continuous variables. All other independent variables were treated as categorical variables.
Outcome
Graft source was categorized into BPTB autograft, hamstring autograft, and allograft. The allograft category included any of the several graft types used in cases because of the small sample size in each of these subcategories.
Statistical Analysis
Descriptive information on the study population is provided using frequencies, proportions, medians, and standard deviations. x 2 tests and Fisher exact test were used to compare proportions of categorical variables across graft choices, and analysis of variance (ANOVA) or Mann-Whitney test was used to compare continuous variables across graft choices. A polychotomous logistic regression was used to model the 3 possible graft selection choices: BPTB autograft, hamstring autograft, and allograft. The BPTB autograft was used as the reference category for the created models. The following variable associations with graft choice were examined: gender (female vs male), race (white, Asian, black, Native American, Hispanic, other, and unknown), age (per 1-year increment), BMI (per 1-kg/m 2 increment), surgeon fellowship training (none, current fellow, completed fellowship), surgeon average yearly volume (small, medium, large), and site yearly volume (small, median, large). Categorical cutoffs for small, medium, and large surgery volumes (\6 cases/ year, 6-51 cases/year, 52 cases/year) and site volumes (\24 cases/year, 24-124 cases/year, 125 cases/year) were obtained from a previously published study. 16 Bivariate models of each of the independent variables were tested to determine associations with graft selection. All independent variables found to be significantly associated with graft selection (all P \ .05) were included in the final fully adjusted model. The variable BMI had missing values that were excluded from the final model, missing observations are reported, and possible bias because of exclusion of cases with missing values was also evaluated. Collinearity of variables was evaluated using tolerance values \.10 as a threshold. Outliers were assessed statistically and then manually reviewed. Odds ratios (ORs) for the association of the independent variables with graft choice and 95% confidence intervals (CIs) are provided. The Wald x 2 test P value is also provided for each variable. All reported P values were considered statistically significant when less than .05. All analyses were performed using SAS for Windows 9.1.3 (Cary, North Carolina).
RESULTS
There were 11 093 ACLRs registered during the study period. After excluding patients who had other concurrent ligament injuries and revision cases (n = 1081) as well as patients with grafts other than the 3 being evaluated in this study (n = 163), 9849 patients remained to be studied. The study cohort had 64.3% male patients, and the median age was 27.7 years (standard deviation [SD], 11.4 years). Of these, 2796 (28.4%) received BPTB autografts, 3013 (30.6%) received hamstring autografts, and 4040 (41.0%) received allografts. See Table 1 for details on graft usage by population characteristics and Table 2 for graft usage by year.
Prevalence of graft source was different between patients' gender, race, age, and BMI categories studied. The proportion of male patients was 69.4% in the BPTB autograft group, 60.3% in the hamstring autograft group, and 63.7% in the allograft group (P \ .001). The median age of the BPTB autograft patients (median, 22.9 years; SD, 9.1 years) was significantly lower than for either hamstring autograft (median, 25.2 years; SD, 10.6 years) or allograft (median, 34.0 years; SD, 11.9 years) groups. Race distribution was significantly different across grafts, with patients with allografts (56.7%) and hamstring autografts (55.2%) having a similar proportion of white patients and the BPTB autograft group (49.0%) having a slightly lower proportion. The BMI was also significantly different, with those receiving hamstring autografts having the lowest median BMI (median, 25.6; SD, 4.8) and patients receiving allografts (median, 26.5; SD, 5.2) and BPTB autografts (median, 26.2; SD, 5.1) having a higher but similar median BMI. Table 3 describes the surgeon and site-specific variables by graft source chosen. Surgeon training (P \ .001), average yearly site volume (P \ .001), and surgeon volume (P \ .001) had significantly different distributions among graft sources. Surgeons who had fellowship training (38.6% of contributing surgeons who performed 66.4% of the cases) performed 39.1% of their operations with allografts, 31.1% with hamstring autografts, and 29.8% with BPTB autografts, whereas surgeons with no fellowship training performed at least 28.9% of the cases and used allografts most frequently (49.6% of their cases). Twenty-one percent of cases were performed by low-volume surgeons, and these surgeons preferred allografts (49%) over BPTB (28.6%) and hamstring (22.4%) autografts. Mediumvolume surgeons (76.6% of the total number of surgeons) used allografts 44.0% of the time, 30.0% with hamstring autografts, and 26.0% with BPTB autografts. High-volume surgeons (2.3% of the surgeons, with 11.4% of cases) used BPTB autografts most commonly (46.4%), followed by hamstring autografts (36.4%) and allografts (17.2%). Graft distribution was also significantly different between different site volumes, with the lowest volume sites (9.5% of the sites, with 3.1% of the cases) doing the highest proportion of allograft cases per yearly volume (53.9%). The highvolume sites (23.8% of the sites and 47.5% of the cases) performed the highest proportion of BPTB autografts (34.4%). Table 4 describes the fully adjusted final model of variables associated with graft selection. The individual Wald x 2 tests indicated that gender (P \ .001), race (P = .018), age (P \ .001), BMI (P \ .001), surgeon training (P \ .001), site volume (P \ .001), and surgeon volume (P \ .001) were associated with graft selection when adjusted for other variables. Fully adjusted models suggest patients receiving allografts have higher odds of being female (OR, 1.47; 95% CI, 1.30-1.66), higher odds of being older (OR, 1.08; 95% CI, 1.07-1.09), and lower odds of having higher BMI (OR, 0.98; 95% CI, 0.97-0.99). Allograft recipients have 1.38 higher odds (95% CI, 1.21-1.58) of undergoing surgery performed by a surgeon with no fellowship training and 0.24 odds (95% CI, 0.18-0.33) of surgery being performed by a surgeon in current fellowship training, 1.93 higher odds (95% CI, 1.71-2.17) of being at a mediumvolume site, and 3.30 higher odds (95% CI, 2.28-4.77) of being at a low-volume site. There are higher odds of allografts having been performed by a medium-volume surgeon (OR, 4.97; 95% CI, 4.05-6.09) or a low-volume surgeon (OR, 3.31; 95% CI, 2.18-5.04) compared with a high-volume surgeon.
Patients receiving hamstring autografts (in relation to patients with BPTB autografts) have 1.44 higher odds (95% CI, 1.29-1.63) of being female; have higher odds of being older (OR, 1.03; 95% CI, 1.02-1.03); have lower odds of being heavier (OR, 0.97; 95% CI, 0.96-0.98); have 1.27 higher odds (95% CI, 1.10-1.45) of undergoing surgery performed by a surgeon with no fellowship training and 0.48 lower odds (95% CI, 0.38-0.61) of surgery being performed by a surgeon in current fellowship training; have higher odds of being at a medium-(OR, 1.25; 95% CI, 1.11-1.41) or low-volume site (OR, 1.55; 95% CI, 1.05-2.82) rather than at a high-volume site; and have higher odds of undergoing surgery performed by a mediumvolume surgeon (OR, 1.45; 95% CI, 1.23-1.71) rather than a high-volume surgeon. Patients receiving hamstring autografts have lower odds of being of an unknown (OR, 0.69; 95% CI, 0.57-0.84) or other (OR, 0.76; 95% CI, 0.63-0.93) race as compared with white recipients than patients receiving BPTB autografts.
DISCUSSION
This analysis describes the prevalence of primary ACLR graft usage and quantifies the association of certain patient, Two locations have contributing current fellows every year. One surgeon was a fellow for a portion of his cases and then fellowship trained for another portion of his cases (n = 215). c P value compares the distribution of row variables by graft type. surgeon, and site characteristics collected by a large community-based registry with graft selection choice. The findings show a diverse pattern in graft usage in the large community-based sample and suggest certain patient and surgeon characteristics may influence a surgeon's decision-making process when making a graft selection.
The prevalence of graft usage in this large sample covering 9849 procedures, by 214 surgeons, and in 42 locations throughout the country shows that the allograft was the most commonly used graft (41%), followed by hamstring autograft (30.6%) and BPTB autograft (28.4%). This is a significantly different pattern of graft usage than reported by other relatively large case series, multisite cohorts, or national ligament registries. 1, 13, 14, 17, 20 In a study on ACLR surgical site infection, Greenberg et al 14 reported on a large case series of ACLR procedures at the University of Missouri. In this series of 861 patients, the proportion of allograft usage was 74%. Conversely, in a large series of 3126 patients from the Hospital for Special Surgery (HSS), the reported usage of allograft was 43%, BPTB autograft was 46%, and hamstring autograft was only 11%. 1 The Multicenter Orthopaedic Outcomes Network had several studies published on its large cohort of patients and reported a similar number of BPBT autograft but inverse proportion of hamstring autograft to allograft as compared with the HSS cohort (approximately 42% BPTB autografts, 44% hamstring autografts, and 13% allografts). 17, 20 Scandinavian countries have national ligament registries and have determined their population graft prevalence. Their national registries report the hamstring autograft to be the most common type of graft used (61%-86% hamstring autograft prevalence depending on the country) and the variation between the countries to be possibly because of surgeon's personal choice, financial considerations, or a combination of these. 13 To our knowledge, 2 previous studies have attempted to describe variables associated with graft selection from a patient's perspective. A cross-sectional study of patients from one medical center with 5 surgeons asked patients what factors influenced their graft selection decision. 7 This study reported that surgeon's recommendation accounted for 74% of the selections. While this study described that surgeon's opinions influence the overall decision, it did not attempt to describe what patient factors are associated with that decision. Similarly, another crosssectional study by Cheung et al 6 found that 75% of patients relied on surgeons' suggestions. To our knowledge, there are no published studies describing preoperative patient, surgeon, and site characteristics associated with graft selection as described in this study.
The patterns of association with graft choice found in this study are most likely representative of the current understanding of the literature by our surgeons and the current practices in their regions of the United States. Studies with large ACLR cohorts have reported consistently that allograft patients are typically older. 2, 9, 15 However, these studies are not consistent in the distribution of gender by graft source, with one reporting higher allograft prevalence in women 2 and one in men, 9 again indicating variation of graft selection patterns in the community. Because no other studies, to our knowledge, have commented on graft distribution of large ACLR cohort by gender, BMI, surgeon fellowship training, surgeon volume, and site volume, this is the first analysis describing the prevalence of graft source by these population characteristics. Some of these associations are interesting to highlight such as the lowest volume sites; non-fellowship-trained surgeons and lowest volume sites are doing the highest proportion of surgeries with allografts. Also, current fellows in this cohort are trained at 2 locations, both of which use BPTB autografts predominately, explaining why a strong inverse association of current fellows with the choice of hamstring autograft and allograft is observed. This suggests the possibility that graduates of these fellowships will most likely continue to use this in their future practice and is in accordance with the findings in this study that fellowship-trained surgeons are more likely to choose BPTB autografts. This study does not allow us to determine the reasons for these findings because of its cross-sectional nature and lack of detailed information on other variables important to ascertain the reasons for graft selection, but we can speculate that these differences are related to surgeons' perceived understanding of graft failure rates, familiarity with graft, ease of graft harvest, associated costs, surgical time, and other similar variables. This study has several potential limitations including the inability to measure surgeon self-reported preferences, lack of preoperative patient-reported quality of life (both general and knee specific), inability to assess patient activity level, lack of ACLR outcome measures, the inclusion of all allograft types under one category, and the obvious limitations involved with using cross-sectional data. Our study utilized data collected by the KP ACLR Registry for its analysis. These data are limited because of the scope of the registry and do not include reported preferences of the surgeon. Because it has been reported that surgeons' preferences are major contributors in the patient's decision of graft selection, this variable is most certainly important in the decision-making process. This study did not attempt to describe surgeons' personal preferences but only examined the existing data from a large ALCR registry. Preoperative general and knee-specific patient-reported quality of life and patient activity level are arguably other factors influencing the surgeons' graft selection process, but again, this was beyond the scope of this study. Another limitation of this study is the lack of association of graft choice and outcomes of the procedures. Outcomes associated with procedures are factors used by surgeons to decide on graft selection; however, this is also out of the scope of this project. The lack of detail on the type of allograft chosen in our study is also a limitation. Surgeons' preference and graft availability are probably drivers of the type of allograft used. Including different types of allograft in this analysis would create many subcategories, some with a low volume of cases, causing our power to estimate associations to decrease. This in-depth analysis by allograft type will most likely be undertaken once larger numbers of cases are entered into the KP ACLR Registry. Finally, the crosssectional nature of these data limits our findings to odds ratios and not risk estimations. Our analysis can only show that certain associations between the independent variables and graft choice exist; no statement can be made on the temporal associations between these variables.
Strengths of this study include the high volume of ACLRs being analyzed, the generalizability of the study findings because of its community-based setting, and the unbiased sample of surgeons included in the analysis. The volume of cases in this analysis allowed us to study the associations of many variables simultaneously in the graft selection process while adjusting for confounding effects of other variables. Univariate associations (ie, female patients get more of a certain graft) can be confounded by other variables (ie, all female patients are younger and therefore are getting a certain graft, suggesting age is also a factor in the choice) and should always be evaluated to prevent misinterpretation of results. Also, the large number of contributing medical centers (n = 42) and surgeons (n = 214) captures a representative sample of community-based practitioners. Inclusion of many centers reduces the bias introduced by studying just a limited number of locations and surgeons that may behave similarly because of proximity and other correlated characteristics. In addition, because of the financial structure of this organization, a staff model health maintenance organization, there is an inherent lack of incentive for greater surgeon volume or choice of specific graft, leading us to believe that there is no financial bias in graft selections made by participating surgeons.
This study has demonstrated that there are many variables associated with graft selection for ACLR procedures. The results from this study are informative to the larger orthopaedic community as it describes the current prevalence of graft usage in a large community-based patient population and it also describes basic patient and surgeon characteristics associated with the procedure's graft selection.
